Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 3/20 | 0.67 |
| ▸ | CNR2 | P34972 | 13/20 | 0.60 |
| ▸ | PSEN1 | P49768 | 2/20 | 0.55 |
| ▸ | PSEN2 | P49810 | 2/20 | 0.55 |
| ▸ | APH1B | Q8WW43 | 2/20 | 0.55 |
| ▸ | NCSTN | Q92542 | 2/20 | 0.55 |
| ▸ | APH1A | Q96BI3 | 2/20 | 0.55 |
| ▸ | PSENEN | Q9NZ42 | 2/20 | 0.55 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | RORA | P35398 | 1/20 | 0.51 |
| ▸ | RORC | P51449 | 1/20 | 0.51 |
| ▸ | RORB | Q92753 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8701533 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL28446594 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL28217298 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL28412652 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL31174405 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL5153575 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL4821945 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL28369278 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL28142613 | 0.99 | PTGER4 (0.66) | PTGER4CNR2PSEN1PSEN2APH1B | |
| SCHEMBL9019646 | 0.96 | PTGER4 (0.69) | PTGER4CNR2PSEN1PSEN2APH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170096426-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | THE UNIV OF MONTANA (US) | 2017-04-06 | — | — | US | disclosed |
| US-20170096426-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | THE UNIV OF MONTANA (US) | 2017-04-06 | — | — | US | disclosed |
| US-20170096426-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | THE UNIV OF MONTANA (US) | 2017-04-06 | — | — | US | disclosed |
| US-20120039804-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | disclosed |
| US-20120039804-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | disclosed |
| US-20120039804-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | disclosed |
| EP-1283448-B1 | Electrophotographic organophotoreceptors with charge transport compounds | SAMSUNG ELECTRONICS CO LTD (KR) | 2008-11-05 | — | — | EP | disclosed |
| US-7358014-B2 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-04-15 | — | — | US | disclosed |
| US-7300732-B2 | Organophotoreceptors with azine-based compounds | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2007-11-27 | — | — | US | disclosed |
| EP-1310489-B1 | Electrophotographic organophotoreceptor with charge transport compounds | SAMSUNG ELECTRONICS CO LTD (KR) | 2006-12-13 | — | — | EP | disclosed |
| US-20050112490-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG ELECTRONICS CO., LTD. | 2005-05-26 | — | — | US | disclosed |
| US-20040219446-A1 | Organophotoreceptors with azine-based compounds | S-PRINTING SOLUTION CO., LTD. (KR) | 2004-11-04 | — | — | US | disclosed |
| EP-1473599-A1 | Organophotoreceptors with azine-based compounds | Samsung Electronics Co., Ltd. (KR) | 2004-11-03 | — | — | EP | disclosed |
| US-6689523-B2 | CHARGE TRANSPORT COMPOUND CONTAINING BIS(3-FORMYLCARBAZOLYL)-1,1'-(SULFONYLDI-4, 1-PHENYLENE)BIS-HYDRAZONES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-02-10 | — | — | US | disclosed |
| US-20030113644-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG ELECTRONICS CO., LTD. | 2003-06-19 | — | — | US | disclosed |
| US-20030113132-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SAMSUNG INFORMATION SYSTEMS AMERICA | 2003-06-19 | — | — | US | disclosed |
| EP-1310489-A1 | Electrophotographic organophotoreceptor with charge transport compounds | Samsung Electronics Co., Ltd. (KR) | 2003-05-14 | — | — | EP | disclosed |
| EP-1283448-A2 | Electrophotographic organophotoreceptors with charge transport compounds | Samsung Electronics Co., Ltd. (KR) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120039804-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | CNR1, CNR2, OPRL1 | PTGER4 287/4885CNR2 2/4885PSEN1 764/4885 |
| US-20030113132-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SLC43A1, SLC18A2, SLC1A1 | PTGER4 3397/4885CNR2 833/4885PSEN1 4739/4885 |
| US-20170096426-A1 | Novel Tricyclic Modulators of Cannabinoid Receptors | CNR1, CNR2, OPRL1 | PTGER4 287/4885CNR2 2/4885PSEN1 764/4885 |
| US-20030113644-A1 | Electrophotographic organophotoreceptors with novel charge transport compounds | SLC26A3, SLC43A1, SLC9A2 | PTGER4 3473/4885CNR2 527/4885PSEN1 4515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.